A phase two study of high dose blinatumomab in Richter’s syndrome
Philip A. Thompson, Xianli Jiang, Pinaki P. Banerjee, Rafet Başar, Naveen Garg, Ken Chen, Mecit Kaplan, Vandana Nandivada, Ana Karen Nunez Cortes, Alessandra Ferrajoli, Michael J. Keating, Christine B. Peterson, Michael Andreeff, Katayoun Rezvani, William G. Wierda
Topics & Concepts
BlinatumomabImmunophenotypingMedicineCytokine release syndromeTIGITInternal medicineImmune checkpointOncologyLymphomaPembrolizumabImmunologyImmune systemCD8CD19ImmunotherapyFlow cytometryChimeric antigen receptorChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentCAR-T cell therapy research